Advances with microRNAs in Parkinson's disease research. - Wikidata - awgldk - TriplyDB

Advances with microRNAs in Parkinson's disease research.

Advances with microRNAs in Parkinson's disease research.

http://www.wikidata.org/entity/Q37221070

about

Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review Current Experimental Studies of Gene Therapy in Parkinson's Disease Biodegradable and biocompatible cationic polymer delivering microRNA-221/222 promotes nerve regeneration after sciatic nerve crush MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7 microRNAs as Biomarker in Depression Pathogenesis Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.microRNAs as novel biomarkers of schizophrenia (Review)Role of MicroRNA Let-7 in Modulating Multifactorial Aspect of Neurodegenerative Diseases: an Overview.Biodegradable Carriers for Delivery of VEGF Plasmid DNA for the Treatment of Critical Limb Ischemia.MicroRNA-181a Regulates Apoptosis and Autophagy Process in Parkinson's Disease by Inhibiting p38 Mitogen-Activated Protein Kinase (MAPK)/c-Jun N-Terminal Kinases (JNK) Signaling Pathways.Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.Altered Tracer Distribution and Clearance in the Extracellular Space of the Substantia Nigra in a Rodent Model of Parkinson's Disease Immune Activities of Polycationic Vectors for Gene Delivery Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis.MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.lncRNA MALAT1/miR-205-5p axis regulates MPP+-induced cell apoptosis in MN9D cells by directly targeting LRRK2.MicroRNAs in depression and suicide: Recent insights and future perspectives MicroRNA-212-5p Prevents Dopaminergic Neuron Death by Inhibiting SIRT2 in MPTP-Induced Mouse Model of Parkinson's Disease

P2860

Q28080047-AD499F34-8744-45FF-BF7E-4661CE5F3C45 Q33627771-1D831BEE-F2D8-4814-8C79-9A453440D5F7 Q33807190-18092FCC-A564-4B7F-9334-00D72245EE35 Q35625246-ECC58B2E-8230-4C2F-A2FF-95B3C906A9E3 Q35654904-EC889BB0-1B26-4E2E-96BD-CD2901CFD806 Q35740789-149F730D-0586-4590-BBB5-732FAA7E3574 Q36584886-5B2594BA-D483-4609-9302-D7394979CA09 Q37643929-407B351C-4999-4F39-A27D-CF4EB73A6849 Q38265172-84086257-9BAD-4858-8197-B7EFC796211A Q38396129-043FB29D-6822-4720-9D4D-76E081C8EBE1 Q38604899-08829B7C-CCDD-46CE-8F1D-FB5559FCF460 Q38709419-1ED7DA6B-7DE5-4F21-B6D0-B43CCD3B9E25 Q38765914-3B99C8D7-85F5-4451-9919-38B7D92D9DEF Q39264615-4B406D34-61D5-4AF9-86A7-8187C99CD8AB Q41108882-378E7C76-BF3C-4ED2-AF5A-CCBC90C3F9E5 Q41245373-1AE21C7C-AABC-467E-823C-FA29606A7E0D Q41455152-8A92CF7E-406F-4436-AD0C-6F4AE50621FC Q47102033-DBF2A2E1-C4BF-49BB-AA53-8034C7FB7BDE Q47214829-D93C9BA4-D7AE-4CDA-8EBA-5E6C92804F55 Q54122835-1A6C05FE-18FD-42AB-8E88-0E254C9D67B4 Q57129924-6C944477-6C60-466A-8BAB-90429A86C08D Q58573076-D7AFB5C3-3FD4-443E-9C5B-251966A376D5

P2860

Advances with microRNAs in Parkinson's disease research.

http://www.wikidata.org/entity/Q37221070

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Advances with microRNAs in Parkinson's disease research.

@en

Advances with microRNAs in Parkinson's disease research.

@nl

type

label

Advances with microRNAs in Parkinson's disease research.

@en

Advances with microRNAs in Parkinson's disease research.

@nl

prefLabel

Advances with microRNAs in Parkinson's disease research.

@en

Advances with microRNAs in Parkinson's disease research.

@nl

P1433

Q37221070-AEF98DFE-82D2-435C-8234-E7D0A355AFAE

P1476

Q37221070-2D4AFD61-43BE-48ED-AB27-CC3999DC6211

P2093

Q37221070-11928F46-ADC9-47FC-AA7C-6BF626262B82

Q37221070-398BCE06-A712-414D-BDDA-1C27E990AFDB

Q37221070-7B9D5140-8C2F-419F-8F3D-50A596C54CAD

Q37221070-D6DBB583-561B-4C33-B824-157400F8B69A

Q37221070-E0E810AA-659C-4027-9FB4-27D8DF1D436A

Q37221070-EB263B20-42A0-43F9-B6A4-910DBBE905AC

P275

Q37221070-BBBC11CE-E209-4176-BF21-9E8CA26C23B2

P2860

Q37221070-0935209F-22DD-481A-BDA9-04AC1C3D0887

Q37221070-0B5D8A45-3671-4931-BFC5-F3003EF2F004

Q37221070-0BAA9386-102E-4CC8-8B25-A41D25F13440

Q37221070-1033ED38-A507-41D5-B25D-C36E3814D2C3

Q37221070-11D6EAA3-B5B8-4E23-BA8D-2A3D824C4C5A

Q37221070-13D3923F-A482-4E9C-B36A-01450D03142B

Q37221070-1471F6B0-2CE2-4AD7-8FCB-39FDEFBC6721

Q37221070-14D0FE93-5CDD-444A-A96F-E63E018BD1B1

Q37221070-19CE00C4-AAF9-4003-ACC3-5C680F40E7AE

Q37221070-1C37B34C-6855-406C-8ABA-8295C7CD42C3

P304

Q37221070-53EE95AC-36ED-4190-887A-A4FA0473702D

P31

Q37221070-BF0E3DF3-046C-4440-BB10-8C96BC7B31AB

Q37221070-C0298848-6196-4618-B608-71A78898CFB3

P356

Q37221070-2B5C9D85-C4AF-43BF-91B4-ED021A3DE503

P407

Q37221070-F7886E9D-2658-48CA-AE99-E9B393873970

P478

Q37221070-1C71A679-5117-46C1-8E5F-00A3D1E9FF91

P5008

Q37221070-6FA334D8-54A0-40FF-B0DC-882DFEB5B175

P577

Q37221070-DBC71ED3-8754-4617-8F18-CCC30A4990EB

P698

Q37221070-0355CE67-7422-401E-96F4-99CA3D7798EC

P921

Q37221070-2EA6E3FD-B887-4D24-A362-97EFEFEF3197

Q37221070-A4BCBC90-CE9B-49F8-8464-AA72DA76683B

Q37221070-BFA1F109-1DDF-41B7-A3FB-ED2CE29AF400

P932

Q37221070-53514740-9466-4FDC-87DB-65E7D14D5125

P356

P1433

Drug Design, Development and Therapy

P1476

Advances with microRNAs in Parkinson's disease research.

@en

P2093

Fei Wu

http://www.w3.org/2001/XMLSchema#string

Liangming Wei

http://www.w3.org/2001/XMLSchema#string

Liuqing Ma

http://www.w3.org/2001/XMLSchema#string

Weien Yuan

http://www.w3.org/2001/XMLSchema#string

Zhenguo Liu

http://www.w3.org/2001/XMLSchema#string

Zhenhua Hu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit

Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing

Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes

MicroRNA genes are transcribed by RNA polymerase II

MicroRNAs: target recognition and regulatory functions

P304

1103-1113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S48500

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24109179

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

biomedical investigative technique

P932

3792848

http://www.w3.org/2001/XMLSchema#string